NUS News and Press, Nu Skin Enterprises Inc.

2026-02-25 11:49:00 ET Heading into an important year, there is a case on paper for Nu Skin Enterprises ( NUS ) stock. Shares are cheap, trading in the range of 3x adjusted EBITDA for 2026. Guidance for this year does seem to have disappointed, sending shares lower, but margins appear s...

2026-02-19 08:55:55 ET Nu Skin ( NUS ) is a potential turnaround stock, but its turnaround might not be complete in 2026. This MLM sells skincare products, and like other MLMs, its market has been shrinking. As a result, Nu Skin is trading at very low multiples on many metrics right...

Dallas, Texas--(Newsfile Corp. - February 13, 2026) - NU Skin Enterprises Inc. (NYSE: NUS): Stonegate Capital Partners updates their coverage on NU Skin Enterprises Inc. (NYSE: NUS). NUS reported revenue, adj NI, and adj EPS of $370.3M, $14.5M, and $0.29, respectively. This compares to our estima...

2026-02-12 21:35:09 ET More on Nu Skin Nu Skin Enterprises, Inc. (NUS) Q4 2025 Earnings Call Transcript Nu Skin: Valuation Is Low, But Challenges Remain Nu Skin Q4 2025 Earnings Preview Seeking Alpha’s Quant Rating on Nu Skin Historical earning...

2026-02-12 21:34:21 ET Nu Skin Enterprises, Inc. (NUS) Q4 2025 Earnings Call February 12, 2026 5:00 PM EST... Read the full article on Seeking Alpha For further details see: Nu Skin Enterprises, Inc. (NUS) Q4 2025 Earnings Call Transcript

2026-02-12 18:27:07 ET Image source: The Motley Fool. Thursday, Feb. 12, 2026 at 5 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-02-12 16:29:28 ET More on Nu Skin Nu Skin: Valuation Is Low, But Challenges Remain Nu Skin Q4 2025 Earnings Preview Seeking Alpha’s Quant Rating on Nu Skin Historical earnings data for Nu Skin Dividend scorecard for Nu Skin Read ...

2026-02-12 16:20:39 ET More on Nu Skin Nu Skin: Valuation Is Low, But Challenges Remain Nu Skin Q4 2025 Earnings Preview Seeking Alpha’s Quant Rating on Nu Skin Historical earnings data for Nu Skin Dividend scorecard for Nu Skin Read ...

Company provides initial outlook for Q1 and fiscal year 2026, forecasting a return to revenue growth by year’s end Nu Skin Enterprises Inc. (NYSE: NUS) today announced fourth quarter and full-year 2025 revenue and earnings within guidance with more than 50% growth in earnings...

Baxter International Inc. (BAX) is expected to report $0.53 for Q4 2025 Nova Ltd. (NVMI) is expected to report $1.94 for Q4 2025 West Pharmaceutical Services Inc. (WST) is expected to report $1.83 for Q4 2025 Universal Logistics Holdings Inc. (ULH) is expected to report $-0.05 for Q4 ...